News Releases Archives

Montana matches SBIR to build diacylglycerol assay

by MT Molecular | Jun 1, 2012

There are advantages to starting up a biotech company in Montana. For instance, companies like Montana Molecular that receive federal SBIR Phase 1 grants are eligible for state matching funds and can be used to help cover patent applications, business development...

Making the most of two photons

by MT Molecular | May 1, 2012

Excellent 3D resolution and minimal photobleaching made possible by multi photon microscopy are important advantages for fluorescence imaging in living cells. Until Misha Drobizhev et.al. tackled the issue, surprisingly little was known about the two photon absorption...

Montana Molecular awarded SBIR from National Institutes of Health

by MT Molecular | Jan 31, 2012

Montana Molecular Awarded 350K SBIR Phase 1 from NIH to develop fluorescent assays for cell-based drug discovery. BOZEMAN, MT. Montana Molecular was awarded an SBIR grant from the National Institute of Mental Health to develop fluorescent tools for detecting signaling...

Multicolored Calcium Imaging

by MT Molecular | Sep 12, 2011

Looking for inspiration? Check out Yongzin Zhao’s et.al’s elegant paper on how the Campbell lab expanded the palette of genetically encoded calcium sensors that modulate fluorescence in response to changes in calcium. An Expanded Palette of Genetically...

Montana Molecular selected for MBRCT Award

by MT Molecular | Jan 14, 2011

Montana Molecular’s breakthroughs in cell based assay technologies have been made possible in part by continued support from the Montana Board of Research and Commercialization. The proposal entitled, “An Integrated Platform for Cell-Based Drug...

Billings Gazette, January 25, 2009

by MT Molecular | Jan 25, 2009

Firm Seeks Tools to Aid in Finding Cures, Billings Gazette, January 25, 2009 Tweets by @livecellassays Archives Archives Select Month February 2019 January 2019 December 2018 November 2018 August 2018 June 2018 May 2018 September 2017 July 2017 June 2017 April 2017...